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Editorial
This article reviews theoretical and practical approaches to 
priority setting in global child health research investments. 
It also provides an overview of previous attempts to devel-
op appropriate tools and methodologies to define priorities 
in health research investments. A brief review of the most 
important theoretical concepts that should govern priority 
setting processes is undertaken, showing how different per-
spectives, such as medical, economical, legal, ethical, social, 
political, rational, philosophical, stakeholder driven, and 
others will necessarily conflict each other in determining pri-
orities. We specially address present research agenda in glob-
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Among the many challenges in global child 
health today, the main is that 10.6 million 
children younger than 5 years still die each 
year (1,2). In The World Health Report 
in 2002, the World Health Organization 
(WHO) identified the leading health risks in 
developing countries as underweight, unsafe 
sex, unsafe water, sanitation and hygiene, iron 
deficiency, and indoor smoke from solid fuels 
(3). Each of those risks heavily affects children 
in a more or less direct way. However, many 
health interventions that could reduce this 
burden are available. Globally, the coverage for 
most of those interventions is below 50%, and 
the children who do not receive them are usu-
ally also the poorest and those exposed to mul-
tiple risk factors listed above (4).
UN’s Millennium Development Goal 4
At a turn of the Millennium, United Nations 
defined its 8 priorities for further development 
– “Millennium Development Goals” (5). One 
of these goals is to reduce child mortality by 
two-thirds between 1990 and 2015. Achiev-
ing this goal required a reliable assessment of 
the main causes of child deaths. In 2001, the 
WHO established the external Child Health 
Epidemiology Reference Group (CHERG) to 
develop estimates of the proportion of deaths 
attributable to each of the main causes in chil-
dren under 5 years of age. This was needed as 
a starting point in further planning and set-
ting priorities, because previous estimates 
varied widely with certain organizations or 
research groups overemphasizing the impor-
tance of some diseases (1). After reviewing all 
the available information, CHERG estimated 
that, over the period 2000-2003, six causes ac-
counted for 73% of deaths in children young-
er than 5 years: pneumonia (19%), diarrhea 
(18%), malaria (8%), neonatal pneumonia or 
sepsis (10%), preterm delivery (10%), and as-
phyxia at birth (8%) (2,6). Undernutrition, as 
a major risk factor in children, was estimated 
to represent the underlying cause of 53% of all 
child deaths globally (5).
Jones et al (4) estimated that, if the exist-
ing interventions for which there is sufficient 
or limited evidence of the effect, and which 
are feasible for delivery at high coverage in 
low-income settings, were made available uni-
versally, a disproportionately high figure of 
63% of child deaths would be prevented each 
year. Subsequently, Bryce et al (7) demonstrat-
ed that there were no financial obstacles to 
fund such an effort given the amount of fund-
ing available, but there is lack of knowledge 
on how to do it. Strategies are needed to reach 
the poor and deprived children and to sustain 
their coverage, and they need to be developed 
through further research.
al child health today and how it relates to United Nation’s (UN) Millennium Development Goal 
4, which is to reduce child mortality by two-thirds between 1990 and 2015. The outcomes of these 
former approaches are evaluated and their benefits and shortcomings presented. The case for a new 
methodology for setting priorities in health research investments is presented, as proposed by Child 
Health and Nutrition Research Initiative, and a need for its implementation in global child health 
is outlined. A transdisciplinary approach is needed to address all the perspectives from which invest-
ments into health research can be seen as priorities. This prioritization requires a process that is trans-
parent, systematic, and that would take into account many perspectives and build on advantages of 
previous approaches.
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Research agenda in global child health
Although the interventions and the financial 
resources needed to achieve Millennium De-
velopment Goal 4 seem available, more than 
half of the period (1990-2015) set by the UN 
has passed and mortality of children globally 
has not decreased enough. It is becoming ap-
parent that the achievement of this goal may 
soon be out of reach. Why is this the case? 
One of the answers may lie in current practic-
es in which funding priorities are being set in 
global child health research. Pneumonia and 
diarrhea, as an example, are jointly responsi-
ble for nearly 40% of all child deaths global-
ly, which is about the same as the number of 
deaths from smoking, double the number of 
deaths from HIV/AIDS, and is 25 times the 
number of deaths from war globally (3). In-
terventions (antibiotics and oral rehydration 
therapy) have been developed and have been 
shown to be highly cost-effective in preventing 
deaths from both diseases in the mid 1980s 
(7), but this appears to be where research in-
terest ended (Figure 1).
There is considerably less interest in re-
search on how to implement these interven-
tions in the context of health services in coun-
tries with limited resources. Implementation 
research is not ranked highly by the scientific 
community or by most funding agencies. As 
it is rarely considered a research priority, re-
search on new interventions far exceeds that 
on delivery. A vaccine against measles has been 
available for decades and it is highly cost-effec-
tive and deliverable, but even in this case only 
about 50% of world’s children have been vac-
cinated (4).
Research funding for global child health 
currently favors opening new frontiers with 
their attractive promises over realizing the 
full public health impact of the interventions 
which led from past advances in knowledge 
(8-11). Even if work on new research avenues 
proves successful, the beneficiaries are only 
those who can afford the results of the re-
search success. This further increases already 
unacceptable levels of inequity. The meth-
odology for setting investment priorities is 
needed which could carefully balance be-
tween long-term investments and supporting 
research on better use of the existing knowl-
edge (12-15).
Instruments (domains) of health research
Current areas of progress in health research 
can be classified into four large (and to some 
extent overlapping) categories from the per-
spective of their potential to reduce persisting 
mortality and morbidity burden (16). Assess-
ment of existing and averted disease burden 
can be achieved through epidemiological re-
search. Further reduction of disease burden 
can then be achieved through health policy 
and systems research, research to improve ex-
isting interventions, and research for devel-
opment of new health interventions. The key 
challenge in setting investment priorities for 
Figure 1. Number of papers with policy-relevant information on epidemiology of spe-
cific childhood illnesses in developing countries identified by Child Health Epidemiol-
ogy Reference Group shows depleting interest in diseases that continue to kill most 
children. MAL – malaria; NEO – neonatal causes; ARI – acute respiratory infections; 
DIA – diarrhea; MB – morbidity; MT – mortality (7).
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health research is to find the right balance of 
investments into those 4 different “instru-
ments” of health research. The aim should be 
to achieve maximum gains in disease burden 
reduction with improved health information, 
efficiency of health systems, and deliverability 
of available interventions, while still support-
ing long-term strategic investments into new 
interventions with large potential to remove 
the existing disease burden.
A history of priority setting in global 
health research investments
1990 - Commission on Health Research for 
Development
The Commission is usually referred to as the 
first truly significant international initiative 
aimed toward systematic approach to setting 
priorities in global health research. It reviewed 
global health needs and priorities for health re-
search and identified great inequity in the allo-
cation of research funds globally – the “10/90” 
gap, where less than 10% of global health re-
search funds is devoted to 90% of the world’s 
health problems. This led to subsequent pro-
motion of the concept of Essential National 
Health Research (ENHR), in which countries 
take responsibilities to delineate a research 
agenda by themselves (17).
1944 – Ad Hoc Committee (AHC) on Health 
Research Relating to Future Intervention Options
The second major initiative in similar direc-
tion came from the World Health Organiza-
tion (WHO), when the Ad Hoc Committee 
on Health Research Relating to Future In-
tervention Options (AHC) was formed. The 
Committee’s mandate was to address: 1) pri-
orities for health research and development, 
2) prospects for funding, and 3) institutional 
changes that might enhance the output of on-
going research and development investments 
at the time. In 1996, Ad Hoc Committee pre-
sented a report “Investing in Health Research 
and Development,” that recommended poli-
cies for investments into research and develop-
ment of particular relevance to poor nations 
(16). Ad Hoc Committee is also credited with 
conceptual framework showing the relation-
ship between different “instruments” of health 
research and their potential to reduce different 
components of disease burden, as presented in 
the previous section (16).
1998 – Global Forum for Health Research
In 1998, the Global Forum for Health Re-
search (GFHR) began its operations with the 
main focus on helping to correct this “10/90” 
gap. It had been holding annual conferenc-
es at which ideas and strategies for correcting 
the “10/90 gap” were exchanged. Working as 
a consultant for Global Forum for Health Re-
search, Hyder wrote a report on priority in-
vestments in research and development (“best 
buys”) identified by Ad Hoc Committee (16). 
Through structured interviews and compre-
hensive review of the literature, and a number 
of other methods that took into account issues 
such as dynamic nature of “best buys,” time 
factor, baseline status, and research intensity, 
17 research and development priorities were 
identified and classified as either “Strategic re-
search,” “Package development and evalua-
tion,” and “New tool or intervention develop-
ment.”
Examples of “Strategic research options” 
were “Sequencing genomes of major patho-
gens responsible for disease burden” or “In-
vestigating factors influencing the devel-
opment of anti-microbial resistance” (16). 
Examples of “Package development and eval-
uation” were “Evaluating and refining the 
package for the Integrated Management of 
Childhood Illness” and “Developing, evalu-
ating and refining the Mother-Baby package 
for pregnancy, delivery and neonatal care” 
(16). Finally, the examples of proposed “New 
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tool or intervention development” research 
options were “Evaluating the efficacy and dos-
age of candidate rotavirus vaccine in low-in-
come countries,” “Evaluating the efficacy of 
candidate conjugate pneumococcal vaccine 
and conducting trials in low-income coun-
tries,” “Developing malaria vaccine,” and “De-
veloping HIV vaccine” (16).
2000 – Council on Health Research and 
Development (COHRED)
In October 2000, an International confer-
ence on health research and development 
was held in Bangkok, Thailand. The confer-
ence was chaired by an international orga-
nizing committee formed by the representa-
tives of the WHO, The World Bank, Global 
Forum for Health Research, and the Coun-
cil on Health Research and Development. 
COHRED reviewed experiences and lessons 
from developing countries (10). The issues 
addressed were systematically categorized 
into the processes and methods for prior-
ity setting, assessing the results of Essential 
National Health Research strategy, defining 
who sets priorities and how to get partici-
pants involved, the potential functions, roles, 
and responsibilities of various stakeholders, 
information and criteria for setting priorities, 
strategies for implementation, and indicators 
for evaluation (10).
2003 – “The Grand Challenges“, World Economic 
Forum, Davos, Switzerland
The next major global initiative emerged at 
the World Economic Forum, held in Davos, 
Switzerland, in January 2003. Bill and Me-
linda Gates Foundation (BMGF) announced 
the release of US$ 200 million to support the 
initiative of “The Grand Challenges” in glob-
al health research. This was based on a model 
formulated by the mathematician David Hil-
bert, who defined ultimate problems in math-
ematics and prizes were then offered to any-
one who would succeed in solving them. This 
initiative resulted in more focused research by 
scientists in mathematics and resulted in ma-
jor progress in the field at the time (11).
The identification of “Grand Challeng-
es” was achieved with financial support from 
BMGF and the National Institutes of Health. 
It gathered a scientific board of 20 scientists 
and public health experts from 13 countries 
(including some developing countries), while 
the scientific community supplied ideas for 
challenges. “Grand Challenge” was described 
as “…a call for a specific scientific or techno-
logical innovation that would remove a critical 
barrier to solving an important health problem 
in the developing world with a high likelihood 
of global impact and feasibility” (11). More 
than 1000 submissions were received from sci-
entists and institutions in 75 countries, and 
scientific board reached the decision on de-
claring 14 submissions as “Grand Challeng-
es” (11). Grants of up to a total of $20 million 
were then made available by Bill and Melinda 
Gates Foundation to remove these major ob-
stacles to progress against diseases that dispro-
portionately affect the developing world (11). 
All of the identified “Grand Challenges” fell 
into 7 broad categories, as follows: “Improving 
childhood vaccines,” “Creating new vaccines,” 
“Controlling insects that transmit agents of 
disease,” “Improving nutrition to promote 
health,” “Improving drug treatment of infec-
tious diseases,” “Curing latent and chronic in-
fections,” and “Measuring disease and health 
status accurately and economically in poor 
countries” (11).
The “17 Best Buys” and the “14 Grand 
Challenges” addressed very similar problems 
and some of them entirely overlapped. The 
key difference was that the “17 Best Buys” 
were generally very specific technologies or in-
terventions already under a certain degree of 
development and targeted at specific diseas-
es, while the “Grand Challenges” were more 
Croat Med J 2007;48:595-604
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broadly and generally defined and could im-
pact several diseases and conditions.
2004 – Combined Approach Matrix, Global Forum 
for Health Research
To improve the process in which the respect-
ed scientists discuss and decide on fund-
ing priorities based on their own views and 
knowledge, Global Forum for Health Re-
search developed a useful tool, the “Com-
bined Approach Matrix” (CAM). The tool 
has proven to be highly useful for systematic 
classification, organization, and presentation 
of the large body of information that is need-
ed at different stages of priority setting pro-
cess, so that the decisions made by the mem-
bers of decision-making committees could be 
based on all relevant and available informa-
tion, rather than their own personal knowl-
edge and judgment.
CAM incorporates “economic” dimen-
sion of priority setting process along one axis, 
and “institutional” dimension along the oth-
er, thus covering the information on the de-
terminants of health at the population level. 
Components of “economic dimension” are 
“disease burden,” its “determinants,” “present 
level of knowledge,” “cost and effectiveness,” 
and “resource flows.” Components of “institu-
tional dimension” are “the individual, house-
hold and community,” “health ministry and 
other health institutions,” “sectors other than 
health,” and “macro-economic policies.” CAM 
can be applied at the level of disease, risk fac-
tor, group or condition, and also at local, na-
tional, or international level (18).
2007 – Research challenges to improve maternal 
and child survival
Over the past several years, The Lancet journal 
bravely engaged into advocacy of internation-
al health issues through publication of several 
series of papers focusing on main priority ar-
eas in international health. Recently, The Lan-
cet expanded this effort through conducting 
a Delphi process similar to the one that had 
led to the “Grand Challenges” among a wide 
range of academics and professionals who 
had experience in developing countries (19). 
The coordinators of the process ranked by 
their perceived importance a limited number 
of very general and broad research themes in 
child health, maternal health, health systems, 
and community development (19).
Assessment of the outcomes of previous 
attempts to define priorities in health 
research investments
All the initiatives from the past aiming to set 
priorities in health research investments re-
sulted in apparent benefits and successes. The 
benefits were that discussions over these is-
sues were taking place and highlighted many 
important factors relevant to setting health 
research priorities. The successes were that a 
more specific research focus was agreed, which 
then attracted attention of many researchers 
groups. The investments began to follow the 
specified goals. Such situation was more favor-
able than having no priorities, when each re-
search group followed its own path.
However, the past approaches were also 
not free from certain shortcomings. Identi-
fied interventions and research questions that 
were outlined as the priorities were not com-
piled in a truly systematic way, using scientif-
ically convincing conceptual framework and 
objective and repeatable methods, but rath-
er through consensus reached by panels of ex-
perts. This often made it difficult to present 
the identified priorities to wider audiences as 
legitimate and fair, as the decisions could be 
seen as driven by research interest bias of indi-
vidual experts.
Also, the claim of “best buys” was not sup-
ported by scientific and repeatable arguments. 
The “best buys” were not consistent or infor-
Rudan et al: Priority Setting for Child Health Research
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mative with respect to their potential for tar-
geted disease burden reduction. The category 
of “package development” represented a mix 
of health policy and systems research options 
and options to improve the existing interven-
tions. Similarly, some items among the “best 
buys” listed as “new tools or interventions” 
were clearly research options addressing the 
improvement of efficacy, affordability, deliv-
erability, or sustainability of existing interven-
tions. More fundamentally, the claim that the 
proposed items are indeed “best buys” was not 
convincingly demonstrated in a scientifically 
based, repeatable manner.
The decision-making process leading to the 
concept of “Grand Challenges,” although bet-
ter designed, informed, explained, and docu-
mented, had a somewhat biased focus from 
the start. The whole process was designed 
so that it largely promoted very difficult up-
stream technology developments. Among the 
“challenges,” there is hardly any that addressed 
the improvement of efficacy, effectiveness, de-
liverability, affordability, and sustainability of 
the existing interventions, so that these impor-
tant instruments of health research were near-
ly ignored. This is particularly unfortunate, be-
cause one of motivations behind the “Grand 
Challenges” initiative was to promote equity. 
Equity, however, is best promoted through de-
livery of the already existing and effective in-
terventions to all children.
One of the conclusions of the recent Lan-
cet’s Child Survival series was a concern that 
global child health is perhaps losing its focus 
(4,8). Amid the large number of new interven-
tions advertised and validated, levels of atten-
tion and effort directed at new, complex, and 
expensive interventions seem to be receiving 
higher profile and funding priority than the 
efforts to save millions of children by applying 
insecticide-treated materials, oral rehydration 
therapy, or promoting breastfeeding, all at a 
tiny fraction of costs of the former (4).
Combined Approach Matrix was launched, 
aiming to ensure that decision-makers are bet-
ter informed about these facts and realities 
when making their decisions (18). However, 
the CAM also has its shortcomings. Although 
it is an extremely helpful tool for gathering 
and organizing information needed for priori-
ty setting process, it does not in itself represent 
an algorithm for making the decisions on the 
priorities by ranking or separating the compet-
ing investment options. Therefore, in the ab-
sence of reliable information, which is usually 
very scarce for developing countries, most of 
the decisions will still be based on discussions 
and agreements within the panels of experts. 
The recent effort by The Lancet made a step 
further in specifying broad research avenues 
that should be considered priorities, but did 
very little to point to more specific research 
programs or research questions which should 
be initiated or addressed urgently (19).
Need for systematic methodology for 
priority setting in global child health 
research investments
Today, investments into health research on 
new interventions far exceed those on delivery 
in spite of the evidence that emphasizes large 
potential contribution of the latter to mor-
tality burden reduction (4,8). The dominant 
model of research priority setting is driven by 
criteria such as interests of different advoca-
cy groups, media exposure, interests of do-
nors, individual biases of the members of pol-
icy-making panels, attractiveness of research 
results, novelty of proposed research and po-
tential for publication in high-impact jour-
nals. We are concerned that continuing ap-
plication of these criteria in decisions over 
investments into health research is resulting 
in gross under-achievement of potential dis-
ease burden reduction and is actually gener-
ating further health inequity. Even when new 
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research avenues succeed in the development 
of new interventions, the initial beneficiaries 
usually are those who can afford the results. 
More complete coverage of the population in 
need often lags decades behind (20).
The current model of research priority 
setting is a closed circle set to increasingly fa-
vor basic research and generate ever-increas-
ing inequity. A major underlying problem 
is lack of clear criteria and principles that 
would guide health research investments 
based on a vision of what the endpoints of 
such investments should be. If we can agree 
that the ultimate endpoint of any health re-
search should be reduction of disease burden 
and improvement of health, then some of the 
criteria needed for prioritization of invest-
ments should include: 1) usefulness of the 
proposed research in terms of its potential 
to lead to development of new or improved 
health interventions, 2) true effectiveness of 
those interventions, 3) their deliverability, af-
fordability, and sustainability in the context 
of interest, and 4) their maximum potential 
to reduce persisting disease burden in an eq-
uitable way.
In addition, there is growing need to 
make decisions on research priorities not 
only globally, but also at lower levels – re-
gional, national, and local community levels, 
and at single health facilities. Because of this, 
a methodology proposed to assist in health 
research priority setting should ideally have a 
form of an algorithm, that would be able to 
rank the priorities in very specific research 
programs or questions in a given setting 
(global, regional, national, and local) and for 
a given disease, risk factor, or a set of diseas-
es and risk factors. Such methodology should 
also be simple enough for application, so that 
it could gain popularity among the users. It 
should provide simple, intuitive, and easily 
understandable answers, so that they could 
be presented to policy-makers from different 
regions of the world and be understood in 
the similar way. The methodology should be 
able to incorporate the available information 
relevant to priority setting (such as that com-
piled by Combined Approach Matrix).
The future application of this new meth-
odology in the area of child health would 
greatly benefit from a particularly favorable 
knowledge base, represented in recently de-
fined global burden of disease and death in 
children based on collective review of over 
17 000 sources and references published over 
the past two decades, that was performed by 
WHO Child Health Epidemiology Refer-
ence Group (CHERG) (2,7,21-25). It would 
also have a solid base for comparatively eval-
uating the competing interventions, through 
the recently completed “Disease Control Pri-
orities Project II” (26).
Designing a new methodology respecting 
the principles of fair and legitimate priority 
setting
There are several fundamental principles that 
need to be respected in order to develop, pro-
mote, and implement priority setting meth-
odology that would have a chance to become 
widely accepted and used. To begin with, Dan-
iels and Sabin (27) defined two main princi-
ples that must underlie any process of setting 
priorities – legitimacy and fairness. Legitima-
cy can only be insured by involving a large and 
diverse range of stakeholders from different 
regions and with different backgrounds into 
development of such methodology.
Respecting the principle of fairness is an 
equally difficult, but in many ways even more 
complex problem. There are different per-
spectives from which prioritizing between 
two or more competing options for health re-
search investments can be made (eg, medical, 
economical, legal, ethical, social, political, ra-
tional, philosophical, stakeholder driven, and 
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others). Even if each process from each sin-
gle perspective was driven through “perfect” 
decisions, the outcomes will necessarily con-
flict each other. Therefore, developing meth-
ods for setting priorities fairly will be a highly 
complex and multidimensional process that 
will require wide agreement of numerous ex-
perts from different disciplines working col-
laboratively to produce such methods.
A standard multidisciplinary approach, 
where researchers work in parallel from their 
respective disciplinary bases to address a 
common problem (as has been usually done 
in the past), would not have a capacity to ad-
dress this particular problem. A transdisci-
plinary approach, where researchers of differ-
ent backgrounds work jointly, using shared 
conceptual frameworks to draw together 
disciplinary specific knowledge and address 
common problems, will be significantly more 
likely to meet the target (28). Encouraging 
steps in providing theoretical guidelines for 
achieving success in transdisciplinary priority 
setting were made by Gibson et al (29), who 
managed to merge ethics principles on how 
priority-setting should be made (“Account-
ability for reasonableness, A4R”) with em-
pirical observations on how priority setting 
is made in absence of any guidelines (“The 
diamond model”) into a single model. Their 
further collaboration with leading represen-
tatives of economy-based model of priori-
ty setting (“Program budgeting and margin-
al analysis”) resulted in the development of a 
joint model that incorporates principles and 
knowledge from all three disciplines – theory 
of ethics, theory of economy, and qualitative 
assessment of how model-free priority setting 
is made in practice – into a satisfactory gen-
eral model (30). The task for Child Health 
and Nutrition Research Initiative (CHNRI) 
experts will be to collaborate with those ex-
perts and continue to expand their work by 
incorporating the principles from medical 
dimension (eg, public health reasoning), so-
cial dimension (eg, concern about equity), 
and public opinion dimension (eg, respecting 
stakeholders’ views) into an even more gen-
eral transdisciplinary framework that could 
be useful in setting health research priori-
ties at all levels. It would also remain open to 
emerging ideas, such as recently presented de-
cision theory and “value of information” con-
cept (31).
Conclusion
The dominant model of priority setting in 
health research investments today contin-
ues to result in gross under-achievement of 
potential disease burden reduction among 
world’s children and is actually generat-
ing further health inequity. There is grow-
ing need for a sound and informed process to 
make decisions on health research priorities, 
both globally and at lower levels – regional, 
national, and local community levels, and at 
single health facilities. A methodology in a 
form of algorithm that would enable this and 
that would be simple and practical enough to 
gain wider acceptance is much needed. In the 
series of papers that will follow this assess-
ment of the past approaches, Child Health 
and Nutrition Research Initiative will propose 
a methodology for prioritization in global and 
national child health and nutrition research 
that attempts to satisfy most of those require-
ments. The proposed methodology will not 
seek to replace the existing methodologies, but 
will attempt to build upon their experiences, 
supplement them with input of knowledge 
and concepts from new and different perspec-
tives, and seek to bring them all together and 
enhance transdisciplinary approach.
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